Eli Lilly vows to extend public&s grant access globally

Share this article:
Eli Lilly, the first drug company to make data on its US educational grants accessible to the public, vowed to extend the policy globally by 2008. Meanwhile, it published its second full quarter of grants online.

Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.